BlackRock Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$309M Buy
3,082,125
+498,371
+19% +$53.4M 0.31% 77
2016
Q3
$326M Buy
2,583,754
+65,108
+3% +$8.04M 0.34% 72
2016
Q2
$294M Buy
2,518,646
+1,330,948
+112% +$151M 0.3% 84
2016
Q1
$123M Buy
1,187,698
+189,400
+19% +$18.3M 0.13% 175
2015
Q4
$99.4M Buy
998,298
+447,908
+81% +$43.8M 0.11% 197
2015
Q3
$50.2M Buy
550,390
+188,917
+52% +$18.9M 0.05% 301
2015
Q2
$38.3M Sell
361,473
-611,100
-63% -$67.6M 0.04% 362
2015
Q1
$111M Sell
972,573
-89,015
-8% -$10.2M 0.11% 203
2014
Q4
$117M Sell
1,061,588
-407,203
-28% -$42.9M 0.12% 195
2014
Q3
$143M Sell
1,468,791
-57,578
-4% -$5.66M 0.14% 166
2014
Q2
$154M Buy
1,526,369
+43,140
+3% +$4.21M 0.15% 168
2014
Q1
$136M Sell
1,483,229
-287,106
-16% -$26.5M 0.13% 180
2013
Q4
$160M Buy
1,770,335
+258,427
+17% +$22.4M 0.15% 163
2013
Q3
$121M Buy
1,511,908
+152,299
+11% +$12M 0.12% 194
2013
Q2
$98.9M Buy
+1,359,609
New +$102M 0.1% 206

Other funds holding ZBH

BlackRock Advisors's ZBH Position: Q4 2016 in Review

BlackRock Advisors increased its Zimmer Biomet (ZBH) stake by 19% in Q4 2016, buying an estimated $53.4M and bringing the position to 3,082,125 shares worth $309M. The position accounts for 0.31% of the portfolio, ranked #77.

BlackRock Advisors first reported a position in ZBH in Q2 2013 and has held it in 15 quarters since. The position peaked at $326M in Q3 2016. 812 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • BlackRock Advisors held 3,082,125 shares of Zimmer Biomet worth $309M as of Q4 2016.
  • BlackRock Advisors bought 498,371 Zimmer Biomet shares in Q4 2016, an estimated $53.4M.
  • Zimmer Biomet made up 0.31% of BlackRock Advisors's portfolio in Q4 2016, its #77 holding.
  • BlackRock Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Zimmer Biomet position peaked at $326M in Q3 2016.
  • 812 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.